Clinical trial

EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD

NCT01796483

Study summary

ClinicalTrials.gov

EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Clonidine (Catapressan) Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Placebo 90 minutes before EEG Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhaseNA

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

Clonidine (Catapressan)DEVICE

Placebo 90 minutes before EEGDEVICE

Sponsors & collaborators

Hospices Civils de Lyonlead sponsor

Mapped research locations

BronFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01796483 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.